Clinical Trial Update: Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing hepato-renal regulation of water conservation in heart failure patients treated with an SGLT-2 inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure

Snippet

Sponsor: National Heart Centre Singapore | Conditions: Diabetes Mellitus, Heart Failure | Phase 4 | Status: COMPLETED